Clinical Trials Browser

Phase 1 × Histiocytoma, Malignant Fibrous × Erlotinib Hydrochloride × Clear all

NCT05827614 2026-01-23

POTENTIATE

Squamous Cell Carcinoma of Head and Neck, Leiomyosarcoma, Histiocytoma, Malignant Fibrous, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms